These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1551745)

  • 1. Secretion of ofloxacin into saliva in patients with respiratory tract infection.
    Takagi K; Hasegawa T; Yamaki K; Suzuki K; Nabeshima T
    Int J Clin Pharmacol Ther Toxicol; 1992 Feb; 30(2):46-50. PubMed ID: 1551745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diffusion of ofloxacin (OFLX) into prostatic tissue in patients with benign prostatic hypertrophy].
    Uchibayashi T; Nagano K; Shoda R; Hisazumi H; Sawaki M; Yamaguchi K; Kawaguchi K; Komatsu K; Kobashi K; Koizumi H
    Hinyokika Kiyo; 1990 Jun; 36(6):741-5. PubMed ID: 1700587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose related pharmacokinetics of ofloxacin in healthy volunteers.
    Immanuel C; Hemanthkumar AK; Gurumurthy P; Venkatesan P
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):1017-22. PubMed ID: 12475149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetic study of ofloxacin using saliva concentration in chronic renal failure].
    Tsubakihara Y; Hayashi T; Shoji T; Kitamura E; Okada N; Nakanishi I
    Nihon Jinzo Gakkai Shi; 1994 Mar; 36(3):246-9. PubMed ID: 8196221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excretion of ofloxacin into saliva in rats with renal failure.
    Ding G; Naora K; Nagasako S; Hirano H; Iwamoto K
    J Pharmacol Exp Ther; 1998 Oct; 287(1):31-6. PubMed ID: 9765318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective monitoring of concentrations of ofloxacin in saliva of patients with chronic respiratory tract infections.
    Koizumi F; Ohnishi A; Takemura H; Okubo S; Kagami T; Tanaka T
    Antimicrob Agents Chemother; 1994 May; 38(5):1140-3. PubMed ID: 8067752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Permeability and concentration of levofloxacin in epithelial lining fluid in patients with lower respiratory tract infections.
    Zhang J; Xie X; Zhou X; Chen YQ; Yu JC; Cao GY; Wu XJ; Shi YG; Zhang YY
    J Clin Pharmacol; 2010 Aug; 50(8):922-8. PubMed ID: 20035039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of ofloxacin through three administration routes.
    Zhuo HT; Lu JZ; Xia XR; Ling SS
    Zhongguo Yao Li Xue Bao; 1994 Sep; 15(5):411-3. PubMed ID: 7717063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ofloxacin concentration in human benign prostatic tissue after oral administration.
    Asakawa M; Yasumoto R
    Hinyokika Kiyo; 1988 Jun; 34(6):1097-9. PubMed ID: 2464915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of ofloxacin in broiler chicken.
    Kalaiselvi L; Sriranjani D; Ramesh S; Sriram P; Mathuram LN
    J Vet Pharmacol Ther; 2006 Jun; 29(3):185-9. PubMed ID: 16669862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ofloxacin concentrations in serum, saliva and pleural effusion of patients with pulmonary tuberculosis and lung cancer.
    Miya T; Hamakubo S; Goya T; Hanaoka T; Hosaka K
    Jpn J Antibiot; 1995 Jul; 48(7):960-4. PubMed ID: 7563589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum and prostatic tissue concentrations of ofloxacin.
    Fujita K; Munakata A
    Clin Ther; 1988; 10 Spec No():32-5. PubMed ID: 3233627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory tract penetration of quinolone antimicrobials: a case in study.
    Ritrovato CA; Deeter RG
    Pharmacotherapy; 1991; 11(1):38-49. PubMed ID: 2020610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of effect of Chinese medicines on bioavailability of ofloxacin in healthy volunteers.
    Hasegawa T; Yamaki K; Nadai M; Muraoka I; Wang L; Takagi K; Nabeshima T
    Int J Clin Pharmacol Ther; 1994 Feb; 32(2):57-61. PubMed ID: 8004359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of levofloxacin after single intravenous and repeat oral administration to cats.
    Albarellos GA; Ambros LA; Landoni MF
    J Vet Pharmacol Ther; 2005 Aug; 28(4):363-9. PubMed ID: 16050816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrapulmonary pharmacodynamics of high-dose levofloxacin in subjects with chronic bronchitis or chronic obstructive pulmonary disease.
    Conte JE; Golden JA; McIver M; Little E; Zurlinden E
    Int J Antimicrob Agents; 2007 Nov; 30(5):422-7. PubMed ID: 17716873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of enoxacin, ofloxacin, and norfloxacin concentration in human benign prostatic tissue].
    Yasumoto R; Asakawa M
    Hinyokika Kiyo; 1988 Aug; 34(8):1519-21. PubMed ID: 3195414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disopyramide concentrations in saliva.
    Aitio ML; Virtanen R; Lammintausta R
    Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):68-72. PubMed ID: 7061181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of ofloxacin penetration into the skin after a single oral dose assessed by cutaneous microdialysis.
    Bielecka-Grzela S; Klimowicz A
    Pol J Pharmacol; 2003; 55(4):613-8. PubMed ID: 14581720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Skin penetration of sulfamethoxazole and trimethoprim after oral administration].
    Królicki A
    Ann Acad Med Stetin; 2002; 48():59-73. PubMed ID: 14601469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.